035610 — Solborn Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapContrarian

Market Cap
KR₩99bn
Enterprise Value
KR₩18bn
Revenue
KR₩121bn

Annual income statement for Solborn, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	R2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	100,199	93,816	119,840	116,081	120,651
Cost of Revenue
Gross Profit	55,751	22,931	80,903	75,408	79,691
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	84,536	120,653	85,960	96,173	98,134
Operating Profit	15,663	-26,837	33,880	19,909	22,517
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	33,895	-45,344	54,941	64,277	46,621
Provision for Income Taxes
Net Income After Taxes	29,967	-41,917	49,713	56,541	34,523
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	17,822	-41,712	38,249	33,940	20,869
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	17,822	-41,712	38,249	33,940	20,869
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	792	-1,864	1,677	1,402	875
Dividends per Share